References
  1. Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: A systematic review and meta-analysis. J Allergy Clin Immunol Pract 2015;3(3):408-416.
  2. Japanese Society of Allergology. Anaphylaxis guideline 2014.https://anaphylaxis-guideline.jp/pdf/anaphylaxis_guideline. pdf Accessed March 11, 2021
  3. Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis–a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol 2020;145(4):1082-1123.
  4. Simons FE, Ebisawa M, Sanchez-Borges M, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J 2015 Oct 28;8(1):32.
  5. Muraro A, Roberts G, Worm M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014;69(8):1026-1045.
  6. Liyanage CK, Galappatthy P, Seneviratne SL. Corticosteroids in management of anaphylaxis; a systematic review of evidence. Eur Ann Allergy Clin Immunol 2017;49(5):196-207.
  7. Grunau BE, Wiens MO, Rowe BH, et al. Emergency department corticosteroid use for allergy or anaphylaxis is not associated with decreased relapses. Ann Emerg Med 2015;66(4):381-389.
  8. Lee S, Bellolio MF, Hess EP, Campbell RL. Predictors of biphasic reactions in the emergency department for patients with anaphylaxis. J Allergy Clin Immunol Pract 2014;2(3):281-287.
  9. Yasunaga H. Real World Data in Japan: Chapter II The Diagnosis Procedure Combination Database. Ann Clin Epidemiol 2019;1(3):76-79.
  10. Ono K, Wada K, Takahara T, Shirotani T. Indications for computed tomography in patients with mild head injury. Neurol Med Chir (Tokyo). 2007;47(7):291-297.
  11. Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009;28(25):3083-3107.
  12. Cole SR, Hernán MA. Constructing inverse probability weights for marginal structural models. Am J Epidemiol 2008;168(6):656-664.
  13. Dilisio MF. Osteonecrosis following short-term, low-dose oral corticosteroids: a population-based study of 24 million patients. Orthopedics 2014;37(7):e631-636.
  14. Kennedy P, Bassiouni A, Psaltis A, Antisdel J, Brunworth J. Avascular necrosis after oral corticosteroids in otolaryngology: Case report and review of the literature. Allergy Rhinol (Providence) 2016;7(1):50-54.
  15. Roberts A, James J, Dhatariya K; Joint British Diabetes Societies (JBDS) for Inpatient Care. Management of hyperglycaemia and steroid (glucocorticoid) therapy: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group. Diabet Med 2018;35(8):1011-1017.
Table 1 . Baseline characteristics of patients treated with and without glucocorticoids according to unmatched and propensity score-matched groups